HEAL ETF Forecast & Price Targets
HEAL Analyst Ratings
Moderate Buy
30Buy8Hold0Sell
Based on the Wall Street analyst consensus for 38 of HEAL’s holdings.
HEAL 12 Month Forecast
Average Price Target
$35.57▲(14.66% Upside)Based on Wall Street analyst 12-month price targets for 38 of Global X HealthTech ETF’s holdings in the last 3 months. The average price target is $35.57 with a high forecast of $43.98 and a low forecast of $28.56. The average price target represents a 14.66% change from the last price of $31.02.
Past 12 Months12 Month ForecastJan2026Oct2026
High$43.98
Average$35.57
Low$28.56
Highest Price TargetHighest$43.98Average Price Target$35.57Lowest Price TargetLowest$28.56
HEAL Stocks With Highest Upside Potential
HEAL Stocks With Highest Downside Potential
HEAL ETF FAQ
What is HEAL’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 38 of HEAL’s holdings, Global X HealthTech ETF’s 12-month average price target is $35.57.
What is HEAL’s upside potential, based on the analysts’ average price target?
HEAL’s average price target of $35.57 represents a 14.66% upside from its last price of $31.02.
Is HEAL a Buy, Sell or Hold?
Global X HealthTech ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 38 of HEAL’s holdings: 30 rated Buy, 8 rated Hold and 0 rated Sell.
What is Global X HealthTech ETF’s price target?
The average price target for Global X HealthTech ETF is $35.57, based on Wall Street analyst 12-month price targets for 38 of HEAL’s holdings, issued in the past 3 months. The highest price target is $43.98 and the lowest is $28.56. The average price target represents a 14.66% increase from the last price of $31.02.
What is HEAL’s expense ratio?
HEAL’s expense ratio is 0.50%.
How many holdings does HEAL have?
HEAL holds 40 assets.
How can I buy shares of HEAL?
You can buy shares of HEAL through a brokerage account. Compare brokers on our Best Online Brokers page.